🌐EnglishEnglishDeutschEspañolFrançaisNederlandsРусскийفارسی中文日本語EntityQ1013888· pop 5· linked from 6 articlesAtagi NobuyasuJapanese samuraiRecent publications · Crossref5 total works indexedDurvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial · 2019 · cited 1,871xMapping the human genetic architecture of COVID-19 · 2021 · cited 816xRosettaScripts: A Scripting Language Interface to the Rosetta Macromolecular Modeling Suite · 2011 · cited 658xErlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations (JO25567): an open-label, randomised, multicentre, phase 2 study · 2014 · cited 617xPrinciples for designing ideal protein structures · 2012 · cited 574xvia Crossref · CC0Connectionsfamily nameEntitySengoku periodEntityCategories1549 births1578 deathsMiyoshi clanSamurai